NuVasive’s XLIF procedure is backed by 10-plus years of clinical evidence.
Here are four observations:
1. The market is set to hit about $2.6 billion by 2024.
2. In 2016, the market was worth about $1.6 billion.
3. Key drivers include the increasing demand of minimally invasive procedures and growing number of spinal disorder cases.
4. The procedure’s costliness, unfavorable reimbursements and a boost in alternative treatments will hinder market growth.
More articles on MIS:
Life Spine launches SI joint fixation screw system
Columbia University Medical Center performs 1st surgery using Titan Medical’s Sport Surgical System: 5 insights
Florida Hospital 1st in US to install minimally invasive surgical robot: 5 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
